Carregant...
Potential role of Hsp90 inhibitors in overcoming cisplatin resistance of bladder cancer-initiating cells
For metastatic bladder cancer patients, systemic cisplatin (CDDP)-based combination chemotherapy is the first-line choice of treatment. Although up to 70% of advanced bladder cancer patients initially show good tumor response to this form of combination chemotherapy, over 90% of good responders rela...
Guardat en:
| Publicat a: | Int J Cancer |
|---|---|
| Autors principals: | , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2011
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7447157/ https://ncbi.nlm.nih.gov/pubmed/21964864 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ijc.26475 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|